Skip to main content
Top
Published in: Abdominal Radiology 6/2022

01-06-2022 | Computed Tomography | Hollow Organ GI

A multicenter study on the preoperative prediction of gastric cancer microsatellite instability status based on computed tomography radiomics

Authors: Xiuqun Liang, Yinbo Wu, Ying Liu, Danping Yu, Chencui Huang, Zhi Li

Published in: Abdominal Radiology | Issue 6/2022

Login to get access

Abstract

Purpose

To construct and validate a radiomics feature model based on computed tomography (CT) images and clinical characteristics to predict the microsatellite instability (MSI) status of gastric cancer patients before surgery.

Methods

We retrospectively collected the upper abdominal or the entire abdominal-enhanced CT scans of 189 gastric cancer patients before surgery. The patients underwent postoperative gastric cancer MSI status testing, and the dates of their radiologic images and clinicopathological data were from January 2015 to August 2021. These 189 patients were divided into a training set (n = 90) and an external validation set (n = 99). The patients were divided by MSI status into the MSI-high (H) arm (30 and 33 patients in the training set and external validation set, respectively) and MSI-low/stable (L/S) arm (60 and 66 patients in the training set and external validation set, respectively). In the training set, the clinical characteristics and tumor radiologic characteristics of the patients were extracted, and the tenfold cross-validation method was used for internal validation of the training set. The external validation set was used to assess its generalized performance. A receiver-operating characteristic (ROC) curve was plotted to assess the model performance, and the area under the curve (AUC) was calculated.

Results

The AUC of the radiomics model in the training set and external validation set was 0.8228 [95% confidence interval (CI) 0.7355–0.9101] and 0.7603 [95% CI 0.6625–0.8581], respectively, showing that the constructed radiomics model exhibited satisfactory generalization capabilities. The accuracy, sensitivity, and specificity of the training dataset were 0.72, 0.63, and 0.77, respectively. The accuracy, sensitivity, and specificity of the external validation dataset were 0.67, 0.79, and 0.60, respectively. Statistical analysis was carried out on the clinical data, and there was statistical significance for the tumor site and age (p < 0.05). MSI-H gastric cancer was mostly seen in the gastric antrum and older patients.

Conclusions

Radiomics markers based on CT images and clinical characteristics have the potential to be a non-invasive auxiliary diagnostic tool for preoperative assessment of gastric cancer MSI status, and they can aid in clinical decision-making and improve patient outcomes.

Graphical abstract

Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71:209-249CrossRef Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71:209-249CrossRef
2.
go back to reference Cristescu R, Lee J, Nebozhyn M, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 2015; 21:449-456CrossRef Cristescu R, Lee J, Nebozhyn M, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 2015; 21:449-456CrossRef
3.
go back to reference Bonneville R, Krook MA, Kautto EA, et al. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis Oncol 2017; 2017 Bonneville R, Krook MA, Kautto EA, et al. Landscape of Microsatellite Instability Across 39 Cancer Types. JCO Precis Oncol 2017; 2017
4.
go back to reference Liu X, Meltzer SJ. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol 2017; 3:348-358CrossRef Liu X, Meltzer SJ. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol 2017; 3:348-358CrossRef
5.
go back to reference Cai L, Sun Y, Wang K, et al. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer. Front Oncol 2020; 10:1269CrossRef Cai L, Sun Y, Wang K, et al. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer. Front Oncol 2020; 10:1269CrossRef
6.
go back to reference van Velzen MJM, Derks S, van Grieken NCT, Haj Mohammad N, van Laarhoven HWM. MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma. Cancer Treat Rev 2020; 86:102024 van Velzen MJM, Derks S, van Grieken NCT, Haj Mohammad N, van Laarhoven HWM. MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma. Cancer Treat Rev 2020; 86:102024
7.
go back to reference Zhao L, Zhang J, Qu X, et al. Microsatellite Instability-Related ACVR2A Mutations Partially Account for Decreased Lymph Node Metastasis in MSI-H Gastric Cancers. Onco Targets Ther 2020; 13:3809-3821CrossRef Zhao L, Zhang J, Qu X, et al. Microsatellite Instability-Related ACVR2A Mutations Partially Account for Decreased Lymph Node Metastasis in MSI-H Gastric Cancers. Onco Targets Ther 2020; 13:3809-3821CrossRef
8.
go back to reference Bibeau F. The MSI status: An almost ideal marker! Ann Pathol 2017; 37:439-440CrossRef Bibeau F. The MSI status: An almost ideal marker! Ann Pathol 2017; 37:439-440CrossRef
9.
go back to reference Duffy MJ, Crown J. Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients. Clin Chem 2019; 65:1228-1238CrossRef Duffy MJ, Crown J. Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer Patients. Clin Chem 2019; 65:1228-1238CrossRef
10.
go back to reference Rodriquenz MG, Roviello G, D'Angelo A, Lavacchi D, Roviello F, Polom K. MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy. J Clin Med 2020; 9 Rodriquenz MG, Roviello G, D'Angelo A, Lavacchi D, Roviello F, Polom K. MSI and EBV Positive Gastric Cancer's Subgroups and Their Link With Novel Immunotherapy. J Clin Med 2020; 9
11.
go back to reference Raimondi A, Palermo F, Prisciandaro M, et al. TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. Cancers (Basel) 2021; 13 Raimondi A, Palermo F, Prisciandaro M, et al. TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study. Cancers (Basel) 2021; 13
12.
go back to reference Svrcek M. Vers un screening systématique du statut MMR déficient/MSI sur toutes les biopsies de cancers de l’estomac. Ann Pathol 2019; 39:381-382CrossRef Svrcek M. Vers un screening systématique du statut MMR déficient/MSI sur toutes les biopsies de cancers de l’estomac. Ann Pathol 2019; 39:381-382CrossRef
13.
go back to reference Fukuda M, Yokozaki H, Shiba M, Higuchi K, Arakawa T. Genetic and epigenetic markers to identify high risk patients for multiple early gastric cancers afte r treatment with endoscopic mucosal resection. J Clin Biochem Nutr 2007; 40:203-209CrossRef Fukuda M, Yokozaki H, Shiba M, Higuchi K, Arakawa T. Genetic and epigenetic markers to identify high risk patients for multiple early gastric cancers afte r treatment with endoscopic mucosal resection. J Clin Biochem Nutr 2007; 40:203-209CrossRef
14.
go back to reference Berry P, Kotha S, Tritto G, DeMartino S. A three-tiered approach to investigating patient safety incidents in endoscopy: 4-year experience in a teaching hospital. Endosc Int Open 2021; 9:E1188-e1195CrossRef Berry P, Kotha S, Tritto G, DeMartino S. A three-tiered approach to investigating patient safety incidents in endoscopy: 4-year experience in a teaching hospital. Endosc Int Open 2021; 9:E1188-e1195CrossRef
15.
go back to reference Kim GH. Systematic Endoscopic Approach for Diagnosing Gastric Subepithelial Tumors. Gut Liver 2022; 16:19-27CrossRef Kim GH. Systematic Endoscopic Approach for Diagnosing Gastric Subepithelial Tumors. Gut Liver 2022; 16:19-27CrossRef
16.
go back to reference Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology 2016; 278:563-577PubMed Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology 2016; 278:563-577PubMed
17.
go back to reference Compter I, Verduin M, Shi Z, et al. Deciphering the glioblastoma phenotype by computed tomography radiomics. Radiother Oncol 2021; 160:132-139CrossRef Compter I, Verduin M, Shi Z, et al. Deciphering the glioblastoma phenotype by computed tomography radiomics. Radiother Oncol 2021; 160:132-139CrossRef
18.
go back to reference Wang W, Cao K, Jin S, Zhu X, Ding J, Peng W. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol 2020; 30:5738-5747CrossRef Wang W, Cao K, Jin S, Zhu X, Ding J, Peng W. Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol 2020; 30:5738-5747CrossRef
19.
go back to reference Li C, Yin J. Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer. Diagnostics (Basel) 2021; 11 Li C, Yin J. Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer. Diagnostics (Basel) 2021; 11
20.
go back to reference Li Z, Zhong Q, Zhang L, et al. Computed Tomography-Based Radiomics Model to Preoperatively Predict Microsatellite Instability Status in Colorectal Cancer: A Multicenter Study. Front Oncol 2021; 11:666786 Li Z, Zhong Q, Zhang L, et al. Computed Tomography-Based Radiomics Model to Preoperatively Predict Microsatellite Instability Status in Colorectal Cancer: A Multicenter Study. Front Oncol 2021; 11:666786
21.
go back to reference Cao Y, Zhang G, Zhang J, et al. Predicting Microsatellite Instability Status in Colorectal Cancer Based on Triphasic Enhanced Computed Tomography Radiomics Signatures: A Multicenter Study. Front Oncol 2021; 11:687771 Cao Y, Zhang G, Zhang J, et al. Predicting Microsatellite Instability Status in Colorectal Cancer Based on Triphasic Enhanced Computed Tomography Radiomics Signatures: A Multicenter Study. Front Oncol 2021; 11:687771
22.
go back to reference Huang Z, Zhang W, He D, et al. Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer: Study Protocol Clinical Trial (SPIRIT Compliant). Medicine (Baltimore) 2020; 99:e19428 Huang Z, Zhang W, He D, et al. Development and validation of a radiomics model based on T2WI images for preoperative prediction of microsatellite instability status in rectal cancer: Study Protocol Clinical Trial (SPIRIT Compliant). Medicine (Baltimore) 2020; 99:e19428
23.
go back to reference Zhang W, Huang Z, Zhao J, et al. Development and validation of magnetic resonance imaging-based radiomics models for preoperative prediction of microsatellite instability in rectal cancer. Ann Transl Med 2021; 9:134CrossRef Zhang W, Huang Z, Zhao J, et al. Development and validation of magnetic resonance imaging-based radiomics models for preoperative prediction of microsatellite instability in rectal cancer. Ann Transl Med 2021; 9:134CrossRef
24.
go back to reference Zhang W, Yin H, Huang Z, et al. Development and validation of MRI-based deep learning models for prediction of microsatellite instability in rectal cancer. Cancer Med 2021; 10:4164-4173CrossRef Zhang W, Yin H, Huang Z, et al. Development and validation of MRI-based deep learning models for prediction of microsatellite instability in rectal cancer. Cancer Med 2021; 10:4164-4173CrossRef
25.
go back to reference Kim JY, Shin NR, Kim A, et al. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol 2013; 47:28-35CrossRef Kim JY, Shin NR, Kim A, et al. Microsatellite instability status in gastric cancer: a reappraisal of its clinical significance and relationship with mucin phenotypes. Korean J Pathol 2013; 47:28-35CrossRef
26.
go back to reference Miyamoto N, Yamamoto H, Taniguchi H, et al. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability. Cancer Lett 2007; 254:42-53CrossRef Miyamoto N, Yamamoto H, Taniguchi H, et al. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability. Cancer Lett 2007; 254:42-53CrossRef
27.
go back to reference Choi J, Nam SK, Park DJ, et al. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma. APMIS 2015; 123:215-222CrossRef Choi J, Nam SK, Park DJ, et al. Correlation between microsatellite instability-high phenotype and occult lymph node metastasis in gastric carcinoma. APMIS 2015; 123:215-222CrossRef
28.
go back to reference Wu MS, Lee CW, Shun CT, et al. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 2000; 27:403-411CrossRef Wu MS, Lee CW, Shun CT, et al. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 2000; 27:403-411CrossRef
29.
go back to reference Chung HW, Lee SY, Han HS, et al. Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography. Gastric Cancer 2013; 16:185-192CrossRef Chung HW, Lee SY, Han HS, et al. Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography. Gastric Cancer 2013; 16:185-192CrossRef
30.
go back to reference Shah MA, Khanin R, Tang L, et al. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011; 17:2693-2701CrossRef Shah MA, Khanin R, Tang L, et al. Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res 2011; 17:2693-2701CrossRef
31.
go back to reference Polom K, Marrelli D, Roviello G, et al. Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability. J Surg Oncol 2017; 115:344-350CrossRef Polom K, Marrelli D, Roviello G, et al. Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability. J Surg Oncol 2017; 115:344-350CrossRef
Metadata
Title
A multicenter study on the preoperative prediction of gastric cancer microsatellite instability status based on computed tomography radiomics
Authors
Xiuqun Liang
Yinbo Wu
Ying Liu
Danping Yu
Chencui Huang
Zhi Li
Publication date
01-06-2022
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2022
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-022-03507-3

Other articles of this Issue 6/2022

Abdominal Radiology 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine